AnPac Bio-Medical Science Co., Ltd. (ANPC) Financials

NASDAQ Currency in USD Disclaimer

$4.30

north_east NA Past Year
Day's range
$4.25
Day's range
$4.63
$50M$50M$0$0-$50M-$50M-$100M-$100M-$150M-$150MEarning201720172018201820192019202020202021202120222022-200%-200%-400%-400%-600%-600%-800%-800%-1000%-1000%Profit Margin
Profit Margin
Revenue
Earnings

ANPC Income statement / Annual

Last year (2022), AnPac Bio-Medical Science Co., Ltd.'s total revenue was $12.04 M, a decrease of 33.04% from the previous year. In 2022, AnPac Bio-Medical Science Co., Ltd.'s net income was -$103.60 M. See AnPac Bio-Medical Science Co., Ltd.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Operating Revenue $12.04 M $17.99 M $20.51 M $10.85 M $10.25 M $5.69 M
Cost of Revenue $3.71 M $5.73 M $7.63 M $6.05 M $5.67 M $3.95 M
Gross Profit $8.34 M $12.25 M $12.88 M $4.80 M $4.58 M $1.73 M
Gross Profit Ratio 0.69 0.68 0.63 0.44 0.45 0.3
Research and Development Expenses $9.53 M $16.20 M $11.58 M $9.84 M $10.11 M $11.41 M
General & Administrative Expenses $70.79 M $80.68 M $74.76 M $70.78 M $28.85 M $24.94 M
Selling & Marketing Expenses $12.15 M $21.42 M $19.67 M $13.63 M $9.83 M $6.49 M
Selling, General & Administrative Expenses $82.94 M $102.10 M $94.43 M $84.41 M $38.67 M $31.43 M
Other Expenses $0.00 -$8.08 M $15.73 M -$373,000.00 -$593,000.00 -$178,000.00
Operating Expenses $92.47 M $118.30 M $106.01 M $93.88 M $48.19 M $42.66 M
Cost And Expenses $96.18 M $124.03 M $113.64 M $99.93 M $53.86 M $46.61 M
Interest Income $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $373,000.00 $4.26 M $1.14 M $2.61 M $925,000.00 $338,000.00
Depreciation & Amortization $5.74 M -$4.04 M $15.71 M -$4.27 M $3.14 M $2.29 M
EBITDA -$78.40 M -$112.10 M -$77.41 M -$93.35 M -$38.19 M -$36.44 M
EBITDA Ratio -6.51 -6.12 -3.77 -8.61 -3.73 -6.41
Operating Income Ratio -6.99 -5.9 -4.54 -8.21 -4.25 -7.2
Total Other Income/Expenses Net -$21.59 M -$9.17 M $13.90 M -$12.76 M $1.11 M $1.61 M
Income Before Tax -$105.73 M -$121.27 M -$80.65 M -$101.84 M -$42.50 M -$39.31 M
Income Before Tax Ratio -8.78 -6.74 -3.93 -9.39 -4.15 -6.91
Income Tax Expense -$2.13 M -$1.18 M -$88,000.00 -$218,000.00 -$199,000.00 $9,000.00
Net Income -$103.60 M -$120.09 M -$80.57 M -$101.62 M -$42.06 M -$39.08 M
Net Income Ratio -8.6 -6.68 -3.93 -9.37 -4.1 -6.87
EPS -54.18 -176.53 -143.99 -205.96 -3.76 -3.49
EPS Diluted -54.18 -176.53 -143.99 -205.96 -3.76 -3.49
Weighted Average Shares Out $1.91 M $680,276.00 $559,504.00 $493,400.00 $11.20 M $11.20 M
Weighted Average Shares Out Diluted $1.91 M $680,276.00 $559,504.00 $493,400.00 $11.20 M $11.20 M
Link